Lionsgate Studios (NYSE:LION) Raised to “Hold” at Zacks Research

Lionsgate Studios (NYSE:LION) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

LION has been the subject of several other reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Lionsgate Studios in a report on Wednesday, October 8th. Benchmark raised their price target on shares of Lionsgate Studios from $8.50 to $11.00 and gave the company a “buy” rating in a research report on Monday, November 24th. Wall Street Zen downgraded shares of Lionsgate Studios from a “hold” rating to a “sell” rating in a research report on Saturday. Barrington Research reissued an “outperform” rating and set a $8.50 target price on shares of Lionsgate Studios in a research note on Friday, November 7th. Finally, Morgan Stanley restated an “overweight” rating and issued a $10.00 price target on shares of Lionsgate Studios in a research note on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $9.14.

Lionsgate Studios Price Performance

Shares of NYSE:LION opened at $8.59 on Monday. The business’s 50-day moving average is $7.65 and its 200 day moving average is $6.81. Lionsgate Studios has a 1 year low of $5.55 and a 1 year high of $9.48. The firm has a market capitalization of $2.49 billion, a P/E ratio of -12.82 and a beta of -0.48.

Lionsgate Studios (NYSE:LION) last announced its quarterly earnings data on Thursday, November 6th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.14). On average, analysts expect that Lionsgate Studios will post 0.08 EPS for the current year.

Insider Activity at Lionsgate Studios

In related news, insider Michael Raymond Burns sold 21,748 shares of the stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $9.01, for a total value of $195,949.48. Following the completion of the transaction, the insider directly owned 3,061,213 shares of the company’s stock, valued at approximately $27,581,529.13. This represents a 0.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Investors Weigh In On Lionsgate Studios

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC raised its position in shares of Lionsgate Studios by 99.3% in the fourth quarter. GAMMA Investing LLC now owns 3,559 shares of the company’s stock valued at $32,000 after buying an additional 1,773 shares during the last quarter. Bessemer Group Inc. purchased a new stake in Lionsgate Studios during the 2nd quarter valued at about $25,000. JTC Employer Solutions Trustee Ltd purchased a new stake in Lionsgate Studios during the 2nd quarter valued at about $26,000. Osaic Holdings Inc. raised its holdings in Lionsgate Studios by 4,852.0% in the 2nd quarter. Osaic Holdings Inc. now owns 4,952 shares of the company’s stock valued at $29,000 after acquiring an additional 4,852 shares during the last quarter. Finally, FNY Investment Advisers LLC purchased a new position in Lionsgate Studios in the 2nd quarter worth approximately $31,000.

About Lionsgate Studios

Lionsgate Studios, operating under the ticker NYSE:LION, is a leading global entertainment company specializing in the production, acquisition and distribution of motion pictures, television programming and digital content. Headquartered in Santa Monica, California, and with additional operations in Vancouver, the company develops, finances and markets feature films that span a wide range of genres—from major franchise hits like The Hunger Games and John Wick to independent and specialty titles.